Tatyana Valentin
Nurse Practitioner · Easton, MDNPI 1659986735
Payments from drug & device makers
Across 275 payments — averaging $17.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$325
- Teva Pharmaceuticals USA, Inc.$307
- Biohaven Pharmaceutical Holding Company Ltd.$305
- Harmony Biosciences LLC$304
- Novartis$250
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,62098%
- Education$1102%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 90 | $1,111 |
| Lilly USA, LLC | 16 | $325 |
| Teva Pharmaceuticals USA, Inc. | 16 | $307 |
| Biohaven Pharmaceutical Holding Company Ltd. | 25 | $305 |
| Harmony Biosciences LLC | 10 | $304 |
| Novartis | 17 | $250 |
| Pfizer | 9 | $187 |
| Jazz Pharmaceuticals Inc. | 7 | $169 |
| Amneal Pharmaceuticals LLC | 7 | $167 |
| Biogen | 7 | $151 |
| Lundbeck LLC | 6 | $138 |
| Biohaven Pharmaceuticals, Inc. | 13 | $138 |
| EMD Serono, Inc. | 6 | $133 |
| Axsome Therapeutics, Inc. | 4 | $105 |
| Bristol Myers Squibb | 5 | $85 |
| Otsuka America Pharmaceutical, Inc. | 4 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $73 |
| Neurocrine Biosciences, Inc. | 3 | $69 |
| Tanabe Pharma America, Inc. | 3 | $67 |
| UCB, Inc. | 3 | $64 |
| Amgen | 3 | $64 |
| Argenx US, Inc. | 3 | $64 |
| Eisai Inc. | 2 | $53 |
| Genentech USA, Inc. | 3 | $51 |
| Life Molecular Imaging Ltd | 2 | $42 |
| AstraZeneca | 1 | $35 |
| Mallinckrodt Hospital Products Inc. | 1 | $31 |
| GE HealthCare | 1 | $31 |
| SK Life Science, Inc. | 1 | $29 |
| Banner Life Sciences, LLC | 1 | $27 |
| Azurity Pharmaceuticals, Inc. | 1 | $24 |
| 3b Medical, Inc. | 1 | $21 |
| Cycle Pharmaceuticals Inc | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
How this compares
$4,730 in reported general payments places this provider in the 95th percentile of 1,562 nurse practitioner providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HorizantGabapentin Enacarbil | 11 | $5,448 |
| Levetiracetam | 121 | $2,949 |
| Nalbuphine Hcl | 12 | $2,484 |
| Galantamine ErGalantamine Hbr | 36 | $2,439 |
| Lacosamide | 16 | $2,083 |
| Gabapentin | 189 | $1,791 |
| Pregabalin | 73 | $1,583 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 101 | $1,569 |
| Donepezil Hcl | 183 | $1,519 |
| Entacapone | 16 | $1,264 |
| Duloxetine Hcl | 103 | $1,163 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 23 | $1,130 |
| Divalproex Sodium ErDivalproex Sodium | 12 | $1,120 |
| Memantine Hcl | 57 | $922 |
| Atorvastatin Calcium | 56 | $836 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Easton
- Doris TateEaston$34K
- Margaret WilliamsEaston$9K
- Morgan GaleRockville$292K
- Sherilyn BrinkleyBaltimore$100K
- Michelle TurnerBaltimore$94K
- Nelli ZafmanLutherville$67K
- Ellen LancasterFallston$52K
- Zeev NemirovskyBaltimore$19K
- Martha ReilleyAnnapolis$18K
- Stephanie ZwonitzerAnnapolis$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.